Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Carcinoma, Basal Cell 2Tongue Neoplasms 1Sezary Syndrome 1Pancreatic Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoid Interstitial Pneumonia 1Keratosis, Actinic 1Basal Cell Nevus Syndrome 1

Interventions

Cisplatin 9Cetuximab 9Radiotherapy, Intensity-Modulated 6Sirolimus 2Platinum 2Fluorouracil 2Docetaxel 2Bevacizumab 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 21,2-diaminocyclohexaneplatinum II citrate 2temsirolimus 1sargramostim 1saracatinib 1dehydroftorafur 1adavosertib 1Vorinostat 1Trioxsalen 1Tobacco Use Cessation Devices 1Soybean Proteins 1Sorafenib 1Salts 1Pilocarpine 1Phototherapy 1Photochemotherapy 1Paclitaxel 1NVP-BKM120 1Moxibustion 1Irinotecan 1Immunoglobulin G 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Tongue Neoplasms × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT02068157 2017-10-11

Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer

Roswell Park Cancer Institute

Phase 2 Terminated
3 enrolled 8 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡